TFX · XBRL financial data
Teleflex financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (TFX's year ends in late December)
| In millions of dollars | Oct 1, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 29, 2024 | Dec 31, 2024 | Mar 30, 2025 | Jun 29, 2025 | Sep 28, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 746 | 774* | 738 | 750 | 764 | 442 | 701 | 781 | 913 | 569 | 548 | 570 |
| Cost of goods and services sold | 330 | 342* | 322 | 333 | 334 | 355* | 311 | 350 | 461 | (250)* | 241 | 239 |
| Gross profit | 416 | — | 416 | 416 | 430 | 269 | 389 | 431 | 452 | 307 | 307 | 332 |
| Research and development | 38 | 36* | 37 | 41 | 39 | 45* | 36 | 39 | 57 | 13* | 44 | 45 |
| Selling, general and administrative | 213 | 261* | 243 | 251 | 247 | 255* | 223 | 215 | 282 | 1* | 226 | 214 |
| Operating income (loss) | 165 | 82* | (5) | 117 | 149 | 52 | 126 | 155 | (409) | 14 | 20 | 73 |
| Interest income | 7 | 3* | 2 | 2 | 2 | 2* | 2 | 2 | 2 | 1* | 2 | 1 |
| Interest expense | 23 | 26* | 23 | 21 | 21 | 19* | 19 | 22 | 32 | 28* | 26 | 28 |
| Income tax expense (benefit) | 12 | 29* | (42) | 17 | 20 | 10* | 14 | 13 | (30) | (31)* | 1 | 3 |
| Net income (loss) | 137 | 31* | 15 | 80 | 111 | (137) | 95 | 123 | (409) | (714) | (8) | 100 |
| Earnings per share, basic USD per share | 2.92 | 0.66* | 0.32 | 1.70 | 2.38 | (2.95) | 2.08 | 2.77 | (9.24) | (16.15) | (0.18) | 2.29 |
| Earnings per share, diluted USD per share | 2.90 | 0.66* | 0.32 | 1.69 | 2.36 | (2.93) | 2.07 | 2.77 | (9.24) | (16.15) | (0.18) | 2.28 |
| Weighted average shares, basic millions of shares | 47 | 47* | 47 | 47 | 47 | 46* | 46 | 44 | 44 | 44* | 44 | 44 |
| Weighted average shares, diluted millions of shares | 47 | 47* | 47 | 47 | 47 | 47* | 46 | 44 | 44 | 44* | 44 | 44 |
Balance sheet
CSVFiscal quarters (TFX's year ends in late December)
Cash flows
CSVFiscal quarters (TFX's year ends in late December)
| In millions of dollars | Oct 1, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 29, 2024 | Dec 31, 2024 | Mar 30, 2025 | Jun 29, 2025 | Sep 28, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 137 | 31* | 15 | 80 | 111 | (137) | 95 | 123 | (409) | (714) | (8) | 100 |
| Stock-based compensation | 8* | 9* | 7 | 9* | 8* | 8* | 8 | 7* | 8* | 3* | 7 | 5* |
| Purchases of property and equipment | 24* | 28* | 38 | 35* | 21* | 32* | 30 | 35* | 30* | 1* | 19 | 14* |
| Net cash from investing activities | (28)* | — | (25) | (30)* | (21)* | — | (29) | (30)* | (768)* | — | — | — |
| Share repurchases | — | 0* | 0 | 0* | 200* | 0* | 300 | 0* | 0* | 0* | 0 | 250* |
| Dividends paid | 16* | 16* | 16 | 16* | 16* | 16* | 15 | 15* | 15* | 15* | 15 | 15* |
| Proceeds from long-term debt | — | 0* | 0 | 0* | 130* | 0* | 300 | 0* | 840* | 0* | 0 | 2,350* |
| Repayments of long-term debt | 167* | 223* | 57 | 41* | 90* | 103* | 49 | 6* | 66* | 31* | 25 | 2,150* |
| Net cash from financing activities | 462* | (238)* | (71) | (57)* | (175)* | (119)* | (60) | (24)* | 756* | (62)* | (45) | (82)* |
| Net change in cash | 631* | (659)* | 15 | 1* | 39* | 50* | (10) | (34)* | 97* | 73* | (85) | (5)* |
Compare with peers
SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Teleflex | 300 | 570 | not reported | 42.4M | — | 10-QJun 30, 2026 |
| Haemonetics | 223 | 339 | 52 | 45.5M | — | 10-QJun 27, 2026 |
| LivaNova | 517 | 391 | 67* | 55.1M | — | 10-QJun 30, 2026 |
| Envista Holdings | 1,126 | 731 | 119* | 160.6M | — | 10-QJul 3, 2026 |
| Enovis | 13 | 583 | 75* | 57.7M | — | 10-QJul 3, 2026 |
| Ufp Technologies | 9 | 174 | 16* | 7.7M | — | 10-QJun 30, 2026 |
| Lemaitre Vascular | 27 | not reported | 16* | 22.9M | — | 10-QJun 30, 2026 |
| Dentsply Sirona | 239 | 898 | 99* | 199.4M | — | 10-QJun 30, 2026 |
| PROCEPT BioRobotics | 228 | 94 | (19)* | 57.3M | 11.8 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.